Conference Session F: 10:15 - 11:30 am
northeast regional nurse practitioner conference
Seminar 26
VERTIGO
Maureen Hughes, MD
Patients who present with dizziness may be describing vertigo, lightheadedness, balance issues, anxiety, or headaches. This session will focus on the assessment and management of vertigo.
Seminar 27
EYE INJURIES AND PREVENTION
Matthew Gardiner, MD
Eye injuries are a common cause of morbidity in the population. Most occur at work or during high risk activities at home. Primary care providers are the front line for identifying these injuries and simple measures can prevent 90% of them.
*Seminar 28
ACUTE MANAGEMENT OF SEPSIS AND SIRS
Thomas Akey, MD
It is essential that acute care providers have the ability to differentiate between systemic inflammatory response syndrome and other stages of sepsis. This session will discuss the latest research and treatment guidelines related to this important topic. Participants will come away with increased knowledge of appropriate management utilizing evidence based research.
*Seminar 29
UPDATE ON PEDIATRIC ASTHMA
Steven Grandgeorge, MD
Childhood asthma is a chronic disorder that can interfere with school, play, sports and sleep. Proper management will minimize the impact of this disorder. In this session, there will be a discussion of the pathophysiology of asthma, including symptoms and history, severity stratification and stepwise therapy recommendations. Patient and parent education is an important component to achieve success and will be included.
Seminar 30
VULVODYNIA-DIAGNOSIS AND TREATMENT
Heidi Hallonquist, MD, ABOG-BC
The most frequent cause of dyspareunia in pre-menopausal women, vulvodynia is characterized by pain, burning, itching and general irritation that can be constant or intermittent. Somewhat challenging to diagnose and even more difficult to treat, effective management of this disorder is critical for the well-being of the affected woman and her partner. In this session, the possible causes/pathophysiology, diagnostic criteria and various treatment approaches will be discussed.
* Eligible for pharmacology contact hours